Abstract
Introduction Innovative technologies over the past decade have emerged to increase uptake in cervical cancer early detection and treatment that could significantly improve screening and precancerous treatment. The changing landscape in cervical cancer screening algorithms and technologies calls for critical inquiries into their implementation in all settings, but especially in low-resource settings with the heaviest burden of disease. Papua New Guinea (Papua New Guinea) has among the highest estimated burden of cervical cancer globally yet has no organized national cervical screening programs. To better understand key informants’ perspectives of a same day point-of-care HPV screen-and-treat program, we conducted key informant interviews to capture their insights into the factors impacting the acceptability and sustainability of the intervention.
Methods We conducted a total of 26 semi-structured interviews with a purposive sample of 20 health care workers and six policymakers from Well Woman Clinics in Madang (Madang Province) and Mt. Hagen (Western Highlands Province). Interviews were conducted in English, transcribed, and analysed using thematic analysis, highlighting factors impacting the acceptability and sustainability of the program from these key informants’ perspectives.
Results The participants perceived the intervention as culturally fit and valuable. Health care workers agreed that the technological elements of the intervention were easy to use and provided the benefit of same day screen-and-treat, which helped to significantly reduce loss to follow-up. Factors such as planning for key resources (i.e., financing, and human resources) and political support were recognised as essential to ensure long-term sustainability by policymakers. The intervention was valued as ‘scalable, portable and simple’, emphasizing that key political support and a comprehensive national cervical cancer prevention strategy could help Papua New Guinea make considerable headway toward cervical cancer elimination.
Conclusion In light of the burden of cervical cancer in the country, all participants agreed that a national cervical screening program, explicitly same day screen-and-treat services using self-collection, addressed an immense unmet need and salient cultural and systemic barriers.
Contribution to literature
This study is the first to explore factors impacting the acceptability and sustainability of a point-of-care HPV self-collect same day screen-and-treat in a low resource setting
The intervention was positively welcomed and assessed by all key informants
Both health care workers and policymakers agree that this service is culturally congruent, easy to use and implement, and is sustainable with consistent political and financial support
Key socio-cultural and systemic factors were identified as caveats that, if raised, could potentially increase acceptability and sustainability of the program
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding was provided by the University of New South Wales scholarship Scientia scheme (to the first author). This study is part of a doctoral research thesis. The other authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted as part of a National Health and Medical Research Council (NHMRC) funded project grant (GNT1104938) “Prospective cohort study to evaluate point-of care HPV-DNA testing for the early detection and treatment of cervical pre-cancer in high-burden, low-resource settings.” This study was approved by the PNG Institute of Medical Research Institutional Review Board (IRB) (No. 1712), the Medical Research Advisory Committee (MRAC) of the PNG National Department of Health (NDoH) (No. 17.36), and the Human Research Ethics Committee at UNSW Sydney (No. HC17631). All participants signed an informed consent before participating in the interviews.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used and analyzed for this study were not made publicly available to protect participants’ privacy but are available from the corresponding author on reasonable request.
